The mTOR Inhibitor Everolimus Induces Proteinuria and Renal Deterioration in the Remnant Kidney Model in the Rat
- 15 December 2007
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 84 (11) , 1492-1499
Abstract
Background. Under certain circumstances the nonnephrotoxic, antiproliferative, immunosuppressive mammalian target of rapamycin (mTOR) inhibitors can cause renal deterioration and proteinuria after conversion from calcineurin inhibitors, especially in long-term renal transplant patients with low glomerular filtration rates. The mTOR inhibitors also show an impaired glomerular healing reaction during acute renal injury in experimental mesangial proliferative glomerulonephritis. In this study, everolimus treatment was investigated in a low nephron number model, the remnant kidney model in rats. Methods. The remnant kidney model was induced by uninephrectomy and infarction of 2/3 of the remaining kidney in 31 male Sprague-Dawley rats. Three days after disease induction, rats were randomly treated either with everolimus or vehicle. Changes in progression of renal disease were investigated by immunohistochemistry on days 22 and 38 after disease induction. Results. In the remnant kidney model, everolimus treatment worsened chronic disease progression as assessed by increased proteinuria, glomerulosclerosis, interstitial fibrosis, glomerular inflammation as well as decreased creatinine-clearance. This result was due to a markedly increased fraction of glomeruli with a defective glomerular architecture in the everolimus group. Everolimus apparently inhibited the chronic glomerular repair reaction via inhibition of the proliferative but not apoptotic activity of the glomerular endothelial and mesangial cells, which was associated with reduced glomerular vascular endothelial growth factor mRNA and protein. In contrast, the fraction of glomeruli with an intact glomerular architecture within the everolimus group showed clearly less glomerular enlargement compared to vehicle-treated nephrectomy rats. Conclusion. This study demonstrates potential mechanisms of mTOR inhibitor induced renal deterioration and proteinuria in the low nephron number remnant kidney model.Keywords
This publication has 21 references indexed in Scilit:
- Everolimus Retards Cyst Growth and Preserves Kidney Function in a Rodent Model for Polycystic Kidney DiseaseKidney and Blood Pressure Research, 2007
- Subtotal nephrectomy impairs ischemia-induced angiogenesis and hindlimb re-perfusion in ratsKidney International, 2006
- Mechanisms of Everolimus‐Induced Glomerulosclerosis After Glomerular Injury in the RatAmerican Journal of Transplantation, 2005
- Rapamycin Ameliorates Proteinuria-Associated Tubulointerstitial Inflammation and Fibrosis in Experimental Membranous NephropathyJournal of the American Society of Nephrology, 2005
- De Novo Kidney Transplantation Without Use of Calcineurin Inhibitors Preserves Renal Structure and Function at Two YearsAmerican Journal of Transplantation, 2004
- Acute rapamycin nephrotoxicity in native kidneys of patients with chronic glomerulopathiesNephrology Dialysis Transplantation, 2004
- Lymphatic Microvessels in the Rat Remnant Kidney Model of Renal FibrosisJournal of the American Society of Nephrology, 2003
- Thrombospondin 1 precedes and predicts the development of tubulointerstitial fibrosis in glomerular disease in the ratKidney International, 1998
- SDZ RAD, A NEW RAPAMYCIN DERIVATIVETransplantation, 1997
- The cytoskeletal linking proteins, moesin and radixin, are upregulated by platelet-derived growth factor, but not basic fibroblast growth factor in experimental mesangial proliferative glomerulonephritis.Journal of Clinical Investigation, 1996